Home Submit Link Suggest Category Latest Link Top Links Contact Us
Statistic

Categories:  (18)
Subcategories:  (2268)
Pending:  (239)
Today:  (77)
Yesterday:  (98)
Total:  (15491)
This weeks:  (400)



Partner
Usato Hi-Fi
wGs Media Web Directory
If you are running a Family Friendly web site with quality content you are welcome to add your web site.wGs Media is seo friendly directory.
Featured + 5 DeepLinks
Regular + 3 DeepLinks


Directory Lists and Resources
Vps Hosting
DataHostDirect.com

has just launched it's own VPS Servers at the cheapest you'll find them on the network! View our current plans on our Plans page. If you have any questions please click the Contact Us link.
 

Links Sort by: PageRank | Hits | Alphabetical

Last minute

In this Dec. 13, 2005 file photo, Rep. John Dingell, D-Mich., smiles in his office on Capitol Hill in Washington. Dingell is part of a congressional committee demanding that the makers of controversial cholesterol drug Vytorin, Merck & Co. and Schering-Plough Corp., produce extensive data related to a clinical study indicating the drug might increase risk of cancer. (AP Photo/Dennis Cook, file)AP - Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer.


HealthDay - (HealthDay News) -- Mercury is found in many types of fish and shellfish. Because significant amounts of mercury can harm unborn babies and young children, women who are or may become pregnant, those who are nursing, and young children should avoid some kinds of seafood.
HealthDay - THURSDAY, Aug. 21 (HealthDay News) -- Zometa (zoledronic acid) prevented bone loss at 12 months in premenopausal women undergoing chemotherapy after they had surgery for early stage breast cancer, a new study found.
HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
HealthDay - THURSDAY, Aug. 21 (HealthDay News) -- In 2007, about 3.4 million Americans enrolled in the Medicare Part D drug plan reached a gap in their prescription coverage known as the "doughnut hole," leading some of them to stop taking prescribed drugs, says a Kaiser Family Foundation study released Thursday.